Meta Platforms, Inc.·4

Mar 24, 9:40 PM ET

Cox Christopher K 4

4 · Meta Platforms, Inc. · Filed Mar 24, 2026

Research Summary

AI-generated summary of this filing

Updated

Meta (META) CPO Christopher K. Cox Receives RSU and Option Awards

What Happened Christopher K. Cox, Chief Product Officer at Meta Platforms, was granted multiple derivative awards on March 20, 2026. The filing lists eight award tranches totaling 733,189 units (79,324; 12,806; 18,066; 29,340; 97,541; 155,491; 249,382; 91,239), all reported at $0.00 per unit (grant/award designation). The awards comprise restricted stock units (RSUs) and stock options rather than open-market purchases or sales — these are compensation grants, not cash transactions.

Key Details

  • Transaction date: March 20, 2026; Form 4 filed March 24, 2026 (filed on-time under the two-business-day rule).
  • Reported consideration: $0.00 per unit; total reported value on the form $0 (standard for grants/derivatives).
  • Total awards: 733,189 derivative units across eight tranches.
  • Shares owned after transaction: Not disclosed in the data provided.
  • Notable footnotes from the filing:
    • F1: Each RSU represents a contingent right to receive one share of Class A common stock upon settlement.
    • F2: RSUs vest quarterly at 1/16th of the total RSUs beginning May 15, 2026, subject to continued service.
    • F3: Options vest and become exercisable during a Price Vesting Period (through Feb 14, 2028) if share price thresholds are met; vesting tied to price and service.
    • F4: Any option tranches not vested during the Price Vesting Period have a time‑based vesting schedule thereafter (6/16ths on Feb 15, 2028, then 1/16th quarterly through Aug 15, 2030), subject to continued service.
  • No 10b5‑1 plan, tax‑withholding, or late‑filing notation was indicated in the provided summary.

Context These are compensation grants (RSUs and stock options), which are common for senior executives and reflect pay structure and future retention incentives rather than immediate buying or selling of shares. RSUs convert to shares upon vesting; options require meeting vesting and (for some tranches) price conditions before becoming exercisable. Such awards do not by themselves signal an insider's view on near‑term stock performance.

Insider Transaction Report

Form 4
Period: 2026-03-20
Cox Christopher K
Chief Product Officer
Transactions
  • Award

    Restricted Stock Units (RSU) (Class A)

    [F1][F2]
    2026-03-20+79,32479,324 total
    Class A Common Stock (79,324 underlying)
  • Award

    Stock Options (right to buy)

    [F3][F4]
    2026-03-20+12,80612,806 total
    Exercise: $1116.08Exp: 2031-03-19Class A Common Stock (12,806 underlying)
  • Award

    Stock Options (right to buy)

    [F3][F4]
    2026-03-20+18,06618,066 total
    Exercise: $1393.87Exp: 2031-03-19Class A Common Stock (18,066 underlying)
  • Award

    Stock Options (right to buy)

    [F3][F4]
    2026-03-20+29,34029,340 total
    Exercise: $1724.41Exp: 2031-03-19Class A Common Stock (29,340 underlying)
  • Award

    Stock Options (right to buy)

    [F3][F4]
    2026-03-20+97,54197,541 total
    Exercise: $2114.87Exp: 2031-03-19Class A Common Stock (97,541 underlying)
  • Award

    Stock Options (right to buy)

    [F3][F4]
    2026-03-20+155,491155,491 total
    Exercise: $2573.06Exp: 2031-03-19Class A Common Stock (155,491 underlying)
  • Award

    Stock Options (right to buy)

    [F3][F4]
    2026-03-20+249,382249,382 total
    Exercise: $3107.44Exp: 2031-03-19Class A Common Stock (249,382 underlying)
  • Award

    Stock Options (right to buy)

    [F3][F4]
    2026-03-20+91,23991,239 total
    Exercise: $3727.12Exp: 2031-03-19Class A Common Stock (91,239 underlying)
Footnotes (4)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement.
  • [F2]The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date.
  • [F3]The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date.
  • [F4]Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date.
Signature
/s/ Erin Guldiken, attorney-in-fact for Christopher K. Cox|2026-03-24

Documents

1 file
  • 4
    dp243961_4-cox.xmlPrimary

    FORM 4